Michelle Tarver, the acting director of the U.S. FDA’s device center appeared on a Sept. 24 webinar to discuss her priorities for the agency going forward, one of which is global health equity.
Chronic pain is taking a significant toll on the mental health and wellbeing of young people across Europe, according to a survey commissioned by Boston Scientific Corp. Among 16 to 24-year-olds, over half feel anxiety multiple times a week due to their chronic pain and almost one in three said that they “feel like they can’t go on” because of their pain.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adifem, Aditxt, Angle, Axena, Evofem, Multiply Labs, Legend Biotech, Mölnlycke, Neurosense, Nuprobe, Ondine, Parmed, Schivo, Spineology.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: B. Braun, Epineuron, Linear Health Sciences, Rhythm AI.
Route 92 Medical Inc. sped past its series F goal, raising an additional $50 million in an extension to the oversubscribed round. The extension brings the total for the series F to $82 million, which the company plans to use to accelerate commercialization of its neurovascular reperfusion and access systems.
Onward Medical NV successfully implanted its Arc-BCI system, which restores direct communication from the brain to the spinal cord enabling lower limb mobility, into a third patient.
RSS
